Power Law company profile

Caris Life Sciences

Biotech & Life Sciences · Irving, United States · Founded 1996 · IPO 2025 Unicorn

A profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics

Valuation

$5.00B

Market cap · May/2026

Revenue

$800M

Latest reported FY

EBITDA

$166M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

22 investors on Caris Life Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 22 investors entered at this stage

Ghisallo Partners

Neuberger Berman

Highland Capital Management

Rock Springs Capital

Empede Capital

Eaton Vance Management

T. Rowe Price

Millennium Management

OrbiMed

CPP Investments

Woodline Partners

First Light Asset Management

Coatue Management

ClearBridge Investments

Tudor Group

Pura Vida Investments

Silver Lake Partners

Fidelity Investments

Columbia Threadneedle Investments

Perceptive Advisors

Millennium Management

Braidwell

Global footprint

Where Caris Life Sciences has talent and traffic

AI talent share

1.7% of workforce is AI talent
(27 of 1,600 staff)

Core AI60.38%

Other AI211.31%

Non-AI workforce1,57398.31%

Workforce by country

10 countries with
team presence

🇺🇸 United States98.7%

🇨🇭 Switzerland0.4%

🇯🇵 Japan0.3%

🇨🇦 Canada0.1%

🇫🇷 France0.1%

Top 5 of 10 shown

Web traffic by country

43K monthly visits
across markets

🇺🇸 United States63%

🇨🇦 Canada5.8%

🇯🇵 Japan4.9%

🇮🇳 India4.7%

🇩🇪 Germany4%

Top 5 markets shown

Patent intelligence

$42M patent portfolio · 24 active families

Estimated portfolio value

$42M

0.84% of market cap · 18.6× smaller than top peer BioNTech ($780M)

24 active patent families

Where Caris Life Sciences innovates Biologic markerDiseaseBioinformaticsMolecular biologyCancer research

Where Caris Life Sciences concentrates vs peers

Each axis is a top-10 topic across Caris Life Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Caris Life Sciences

An AI-synthesized read of the highest-engagement posts about Caris Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Caris Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles